Ameritas Advisory Services’s Twist Bioscience TWST Stock Holding History

Ameritas Advisory Services’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.6K	Buy	+103	New	+$6.7K	﹤0.01%	1466
2025 Q3	–	Sell	-100	Closed	-$3.68K	–	2875
2025 Q2	$3.68K	Buy	+100	New	+$3.46K	﹤0.01%	2329
2023 Q2	–	Sell	-225	Closed	-$3.07K	–	2371
2023 Q1	$3.07K	Buy	+225	New	+$4.97K	﹤0.01%	2291

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Ameritas Advisory Services's TWST Position: Q2 2026 in Review

Ameritas Advisory Services opened a new position in Twist Bioscience (TWST) in Q2 2026: 103 shares worth $10.6K. The stake represents ﹤0.01% of the portfolio and ranks #1466 among its holdings. This is a return to the name: Ameritas Advisory Services previously reported a position in TWST as recently as Q2 2025.

Ameritas Advisory Services first reported a position in TWST in Q1 2023 and has held it in 3 quarters since. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Ameritas Advisory Services held 103 shares of Twist Bioscience worth $10.6K as of Q2 2026.
Twist Bioscience was a new Ameritas Advisory Services position in Q2 2026.
Twist Bioscience made up ﹤0.01% of Ameritas Advisory Services's portfolio in Q2 2026, its #1466 holding.
Ameritas Advisory Services first reported a position in Twist Bioscience in Q1 2023 and has held it in 3 quarters since.
337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.